Published in Ann Intern Med on March 01, 1986
Molecular characterization of two human autoantigens: unique cDNAs encoding 95- and 160-kD proteins of a putative family in the Golgi complex. J Exp Med (1993) 1.64
Central nervous system involvement in Sjogren's syndrome. Ann Rheum Dis (2004) 1.26
Clinical manifestations of neurological involvement in primary Sjögren’s syndrome. Clin Rheumatol (2011) 1.07
Neurological Disorders in Primary Sjögren's Syndrome. Autoimmune Dis (2012) 1.07
Demyelination in rheumatic diseases. J Neurol Neurosurg Psychiatry (2006) 0.88
A clinically isolated syndrome: a challenging entity: multiple sclerosis or collagen tissue disorders: clues for differentiation. J Neurol (2009) 0.86
A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis. J Neurol (2011) 0.83
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma. Case Rep Neurol Med (2014) 0.82
Auricular chondritis and diffuse proliferative glomerulonephritis in primary Sjögren's syndrome. Ann Rheum Dis (1989) 0.79
Degree of modification of Ro60 by the lipid peroxidation by-product 4-hydroxy-2-nonenal may differentially induce Sjögren syndrome or systemic lupus erythematosus in BALB/c mice. Free Radic Biol Med (2010) 0.79
Sjögren's syndrome and neuromyelitis optica spectrum disorders (NMOSD)--a case report and review of literature. BMC Neurol (2014) 0.78
The presence of oligoclonal IgG bands in human CSF during the course of neurological diseases. J Neurol (2014) 0.77
Autoimmune encephalopathy. Mayo Clin Proc (2010) 0.77
Nervous system disease, immunological features, and HLA phenotype in Sjögren's syndrome. Ann Rheum Dis (1992) 0.75
Clinical Features of Neuropsychiatric Syndromes in Systemic Lupus Erythematosus and Other Connective Tissue Diseases. Clin Med Insights Arthritis Musculoskelet Disord (2016) 0.75
If Neurologists Establish The Diagnosis of Primary Sjogren's Syndrome? Noro Psikiyatr Ars (2014) 0.75
Bilateral Internuclear Ophthalmoplegia as a Presenting Manifestation of Primary Sjögren's Syndrome. Neuroophthalmology (2016) 0.75
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis (2002) 20.48
Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci (1986) 18.17
Neuron activity related to short-term memory. Science (1971) 5.76
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA (2001) 5.13
Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc Natl Acad Sci U S A (2001) 4.26
Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol (1998) 3.68
Role of the posterior parietal cortex in updating reaching movements to a visual target. Nat Neurosci (1999) 3.39
Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease. Ann Neurol (1992) 2.59
Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome. Arthritis Rheum (1986) 2.39
Subsets in systemic lupus erythematosus. J Invest Dermatol (1979) 2.30
Serological findings in patients with "ANA-negative" systemic lupus erythematosus. Medicine (Baltimore) (1981) 2.27
Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology (1998) 2.24
Relationship between lifetime occupation and parietal flow: implications for a reserve against Alzheimer's disease pathology. Neurology (1995) 2.24
Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) (1985) 2.01
Bullous pemphigoid. Clinical and immunologic follow-up after successful therapy. Arch Dermatol (1977) 1.90
Activation of brain regions vulnerable to Alzheimer's disease: the effect of mild cognitive impairment. Neurobiol Aging (2005) 1.88
Ethylenediamine contact dermatitis. Arch Dermatol (1967) 1.80
Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid. J Clin Invest (1973) 1.73
Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med (1983) 1.68
Role of posterior parietal cortex in the recalibration of visually guided reaching. Nature (1996) 1.66
Epidermolysis bullosa acquisita: ultrastructural and immunological studies. J Invest Dermatol (1981) 1.55
The metabolic topography of normal aging. J Cereb Blood Flow Metab (1996) 1.54
The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol (1979) 1.51
Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science (1986) 1.50
Neonatal lupus erythematosus: new serologic findings. J Invest Dermatol (1981) 1.49
Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls). Biol Psychiatry (1998) 1.44
Preferential representation of instructed target location versus limb trajectory in dorsal premotor area. J Neurophysiol (1997) 1.43
High-grade atrioventricular heart block in an adult with systemic lupus erythematosus: the association of nuclear RNP (U1 RNP) antibodies, a case report, and review of the literature. Arthritis Rheum (1989) 1.43
F(ab')2 reagents are not required if goat, rather than rabbit, antibodies are used to detect human surface immunoglobulin. J Immunol (1977) 1.43
Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study. Neurology (2001) 1.35
Neurologic complications of primary Sjögren's syndrome. Medicine (Baltimore) (1982) 1.34
The immunopathology of herpes gestationis. Immunofluorescence studies and characterization of "HG factor". J Clin Invest (1976) 1.33
Characterization of the image-derived carotid artery input function using independent component analysis for the quantitation of [18F] fluorodeoxyglucose positron emission tomography images. Phys Med Biol (2007) 1.31
Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature. Medicine (Baltimore) (1984) 1.30
Microstimulation of the primate neostriatum. II. Somatotopic organization of striatal microexcitable zones and their relation to neuronal response properties. J Neurophysiol (1985) 1.28
Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus. Arthritis Rheum (1982) 1.27
A high-yield technique for preparing cells fixed in suspension for scanning electron microscopy. J Cell Biol (1975) 1.27
Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis. Arch Neurol (1998) 1.25
Role of basal ganglia in limb movements. Hum Neurobiol (1984) 1.24
Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded "stress test" during PET. Am J Psychiatry (1996) 1.23
Subacute sensory neuronopathy secondary to dorsal root ganglionitis in primary Sjögren's syndrome. Ann Neurol (1986) 1.22
Human leukocyte Fc (IgG) receptors: quantitation and affinity with radiolabeled affinity cross-linked rabbit IgG. J Immunol (1979) 1.21
Functional anatomy of saccadic adaptation in humans. Nat Neurosci (1998) 1.21
Interactive effects of age and hypertension on volumes of brain structures. Stroke (1997) 1.19
Developmental assessment in general practice. A survey of 151 infants. Practitioner (1971) 1.16
Movement-related neuronal activity selectively coding either direction or muscle pattern in three motor areas of the monkey. J Neurophysiol (1990) 1.16
Sjögren syndrome: central nervous system manifestations. Neurology (1981) 1.15
Two histopathologic types of inflammatory vascular disease in MRL/Mp autoimmune mice. Model for human vasculitis in connective tissue disease. Arthritis Rheum (1985) 1.15
Human lymphocytes: similarity of B and T cell surface morphology. Science (1975) 1.14
Infant morbidity and obesity. A survey of 151 infants from general practice. Practitioner (1971) 1.13
Antibodies to cytoplasmic antigens in lupus erythematosus. Serologic marker for systemic disease. Arthritis Rheum (1977) 1.13
Unusual subepidermal bullous diseases with immunologic features of bullous pemphigoid. Arch Dermatol (1979) 1.12
Functional anatomy of nonvisual feedback loops during reaching: a positron emission tomography study. J Neurosci (2001) 1.12
Ovarian cancer in patients with dermatomyositis. Medicine (Baltimore) (1994) 1.11
Primary Sjögren's syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds. Ann Intern Med (1984) 1.11
Functional development of the dorsolateral prefrontal cortex: an analysis utlizing reversible cryogenic depression. Brain Res (1978) 1.10
Homozygous C2 deficiency, lupus erythematosus, and anti-Ro (SSA) antibodies. Arthritis Rheum (1983) 1.08
Pemphigus vulgaris. Superior sensitivity of monkey esophagus in the determination of pemphigus antibody. Arch Dermatol (1981) 1.08
The coexistence of rheumatoid arthritis with Reiter's syndrome and/or ankylosing spondylitis: a model of dual HLA-associated disease susceptibility and expression. J Rheumatol (1981) 1.08
In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET. J Neural Transm (Vienna) (2002) 1.07
Neural correlates of a spatial sensory-to-motor transformation in primary motor cortex. J Neurophysiol (1997) 1.07
Functional organization of the basal ganglia: contributions of single-cell recording studies. Ciba Found Symp (1984) 1.07
High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study. Am J Psychiatry (1999) 1.06
Two types of inflammatory vascular disease in Sjögren's syndrome. Differential association with seroreactivity to rheumatoid factor and antibodies to Ro (SS-A) and with hypocomplementemia. Arthritis Rheum (1985) 1.06
Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes: a replication study. J Neurol Sci (2001) 1.06
Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis. Ann Intern Med (1986) 1.05
Physiologic properties and somatotopic organization of the primate motor thalamus. J Neurophysiol (1994) 1.05
Primary Sjögren's syndrome in men. Clinical, serologic, and immunogenetic features. Am J Med (1986) 1.05
Lymphocyte transformation induced by inorganic and organic mercury. Int Arch Allergy Appl Immunol (1970) 1.04
Immunopathology of bullous pemphigoid. Basement membrane deposition of IgE, alternate pathway components and fibrin. Clin Exp Immunol (1974) 1.04
Movement sequence-related activity reflecting numerical order of components in supplementary and presupplementary motor areas. J Neurophysiol (1998) 1.04
Sjögren's syndrome. Influence of multiple HLA-D region alloantigens on clinical and serologic expression. Arthritis Rheum (1984) 1.04
Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory. Proc Natl Acad Sci U S A (1997) 1.02
Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome. J Rheumatol (1982) 1.02
Quantitation of Fc receptors and surface immunoglobulin is affected by cell isolation procedures using plasmagel and ficoll-hypaque. J Immunol Methods (1978) 1.02
Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration. Neurobiol Aging (2002) 1.01
The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease. Arch Neurol (2001) 1.01
Pemphigus and myasthenia gravis. Arch Dermatol (1975) 1.00
Thrombocytopenia in the neonatal lupus syndrome. Arch Dermatol (1988) 0.99
Neuropsychiatric disease in Sjögren's syndrome: anti-ribosomal P and anti-neuronal antibodies. Am J Med (1993) 0.98
Dermatomyositis sine myositis: association with malignancy. J Rheumatol (1996) 0.98
Value of immunofluorescent techniques in studies of bullous disease. Am J Dermatopathol (1983) 0.97
Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications. Am J Psychiatry (1996) 0.97
Combined immune deficiency, autoantibody formation, and mucocutaneous candidiasis. Clin Immunol Immunopathol (1973) 0.96
Pemphigus foliaceus: a case with serologic features of Senear-Usher syndrome and other autoimmune abnormalities. J Am Acad Dermatol (1982) 0.96
Lupus band test. Int J Dermatol (1981) 0.96
Functional adaptation of reactive saccades in humans: a PET study. Exp Brain Res (2000) 0.96
Systemic lupus erythematosus: current state of the genetic hypothesis. Semin Arthritis Rheum (1984) 0.94
Functional development of frontal association cortex in monkeys: behavioural and electrophysiological studies. Neurosci Res Program Bull (1982) 0.94